News

News Archive

Karyopharm and Menarini Receive Full Marketing Authorisation from the European Commission for NEXPOVIO® (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy

Karyopharm and Menarini Receive Full Marketing Authorisation from the European Commission for NEXPOVIO® (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy

NEWTON, Mass. and FLORENCE, Italy, – July 21, 2022 – Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies,...
Sport’s finest gather under the stars for the grand finale of the XXVI Fair Play Menarini International Award

Sport’s finest gather under the stars for the grand finale of the XXVI Fair Play Menarini International Award

FLORENCE, 8th July 2022 – Intense emotions and immense satisfaction were in the air during the final event of the XXVI Fair Play Menarini International Award. Yesterday evening,...

Select a Year from the Archive

Our values

Our values

Everyday we put our values into action. 4 values, which have given life to Menarini and have shaped its history.

Read More

Our values

Follow our blog

Discover our stories from all over the world

Read More